Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

002424 Guizhou Bailing Group Pharmaceutical Co.,Ltd.

Closed 12-23 15:00:00

5.35

-0.28

-4.97%

High5.35	Low5.35	Vol467.90K
Open5.35	D1 Closing5.63	Amplitude0.00%
Mkt Cap7.48B	Tradable Cap6.49B	Total Shares1.40B
T/O2.50M	T/O Rate0.04%	Tradable Shares1.21B
P/B2.41	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.","latestPrice":5.35,"timestamp":1766473410000,"preClose":5.63,"halted":0,"volume":467900,"delay":0,"changeRate":-0.0497,"floatShares":1213000000,"shares":1398000000,"eps":0.0016,"marketStatus":"Closed","change":-0.28,"latestTime":"12-23 15:00:00","open":5.35,"high":5.35,"low":5.35,"amount":2503300,"amplitude":0,"askPrice":5.35,"askSize":1262965,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.0016,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.63,"symbolType":"stock","openAndCloseTimeList":[[1766453400000,1766460600000],[1766466000000,1766473200000]],"highLimit":5.91,"lowLimit":5.35,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1397598400,"isCdr":false,"pbRate":2.41,"roa":"--","peRate":3343.75,"roe":"1.77%","epsLYR":0.02,"committee":0,"marketValue":7477000000,"turnoverRate":0.0004,"status":1,"floatMarketCap":6491000000},"requestUrl":"/m/hq/s/002424/tweets","defaultTab":"tweets","newsList":[{"id":"1147767611","title":"Guizhou Bailing Faces ST Label Due to Financial Fraud, Investors Eligible for Compensation Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1147767611","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147767611?lang=en_us&edition=fundamental","pubTime":"2025-12-22 15:32","pubTimestamp":1766388738,"startTime":"0","endTime":"0","summary":"Affected investors can register their claims on the Sina Investor Rights Protection Platform: http://wq.finance.sina.com.cn/. Follow @Sina Securities or visit the Sina Finance app or homepage for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","002424","BK0028","BK0183","BK0077","BK0239","BK0146"],"gpt_icon":0},{"id":"1140669422","title":"Guizhou Bailing, Funeng Oriental, and Ba Yi Steel Receive Advance Notice of Administrative Penalties; Investors Eligible for Compensation Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669422","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140669422?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:03","pubTimestamp":1766376230,"startTime":"0","endTime":"0","summary":"Affected investors can register their claims on the Sina Investor Rights Protection Platform: http://wq.finance.sina.com.cn/. On the evening of December 19, 2025, Guizhou Bailing (Rights Protection),...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0212","BK0029","BK0010","BK0146","BK0251","BK0006","300173","BK0130","BK0111","600581","BK0239","BK0028","BK0181","BK0061","002424","BK0077","BK0186","BK0183","BK0188"],"gpt_icon":0},{"id":"1146288517","title":"Market Highlights: Key Positive and Negative News Affecting Stocks on December 22, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1146288517","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146288517?lang=en_us&edition=fundamental","pubTime":"2025-12-22 08:56","pubTimestamp":1766365017,"startTime":"0","endTime":"0","summary":"1. The Ministry of Commerce held an expanded party group meeting in Beijing on December 20, emphasizing efforts to boost consumption, expand high-quality goods and services, and unleash the potential...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","LU0823421333.USD","002424","LU1861219969.SGD","LU1064131342.USD","LU1923623000.USD","LU0823434740.USD","LU0823434583.USD","300173","LU1303367103.USD","LU1988902786.USD","LU2264538146.SGD","301213","LU1861558580.USD","LU0127658192.USD","LU1861559042.SGD","IE0004445239.USD","LU1989764664.SGD","LU2250418816.HKD","LU1861214812.USD","BK4529","LU0082616367.USD","LU1803068979.SGD","LU1951198990.SGD","ST","BK4614","LU0274383776.USD","LU2089985449.USD","LU1880398471.USD","LU2355687059.USD","BK4543","BK4512","LU0081259029.USD","LU1242518857.USD","LU1242518931.SGD","LU2458330243.SGD","BK4566","AMD","BK4532","LU0979878070.USD","IE00BMPRXN33.USD","BK4534","IE0009356076.USD","LU2360106780.USD","BK4575","LU2458330169.SGD","LU1880398554.USD","LU2931357623.SGD","LU0889565833.HKD","LU0390134368.USD","BK4588","LU2054465674.USD","BK4554","LU0056508442.USD","LU1852331112.SGD","BK4612","LU2098885051.SGD","LU1951200564.SGD","LU0823421416.USD","LU0642271901.SGD","688121","IE00B5949003.HKD","BK4096","BK4605","BK4141","BK4573","IE00BMPRXR70.SGD","LU1316542783.SGD","LU0719512351.SGD","BK4585","LU0109392836.USD"],"gpt_icon":1},{"id":"1169454131","title":"Guizhou Bailing Group Pharmaceutical Co.,Ltd. (002424) Faces Regulatory Action Over Years of Financial Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=1169454131","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169454131?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:41","pubTimestamp":1766151682,"startTime":"0","endTime":"0","summary":"Guizhou Bailing Group Pharmaceutical Co.,Ltd. (002424) announced on December 19 that the company and related parties received a prior notice of administrative penalties from the Guizhou Securities...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0188","BK0183","BK0146","BK0028","BK0077","002424"],"gpt_icon":0},{"id":"1157102599","title":"Guizhou Bailing (002424.SZ) Faces Other Risk Warning Due to False Records in 2019-2021 and 2023 Annual Reports; Stock Abbreviation to Change to \"ST Bailing\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1157102599","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157102599?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:32","pubTimestamp":1766147547,"startTime":"0","endTime":"0","summary":"Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) announced that the company and relevant personnel received the \"Prior Notice of Administrative Penalty\" from the Guizhou Securities...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","002424","BK0239","BK0028","BK0077","BK0146","BK0188"],"gpt_icon":0},{"id":"2592161493","title":"BRIEF-Guizhou Bailing's Trading To Halt To Implement Other Risk Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2592161493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592161493?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:25","pubTimestamp":1766147149,"startTime":"0","endTime":"0","summary":"BRIEF-Guizhou Bailing's Trading To Halt To Implement Other Risk WarningDec 19  - Guizhou Bailing Group Pharmaceutical Co Ltd 002424.SZ:SAYS TRADING IN CO SHARES TO HALT ON DEC 22 TO IMPLEMENT OTHER RISK WARNINGSAYS TRADING TO RESUME FROM DEC 23Source textFurther company coverage: 002424.SZ  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL4N3XP0WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0146","BK0028","BK0239","BK0183","002424","BK0188","BK0077"],"gpt_icon":0},{"id":"2592161106","title":"Guizhou Bailing Group Pharmaceutical  Says Trading in Co Shares to Halt on Dec 22 to Implement Other Risk Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2592161106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592161106?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:25","pubTimestamp":1766147149,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL4N3XP0WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["002424","BK0188","BK0028","BK0239","BK0146","BK0077","BK0183"],"gpt_icon":0},{"id":"1145073389","title":"The Vanished Billion-Dollar Market Cap and the Mysterious White Knight of Guizhou Bailing","url":"https://stock-news.laohu8.com/highlight/detail?id=1145073389","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145073389?lang=en_us&edition=fundamental","pubTime":"2025-12-19 10:51","pubTimestamp":1766112670,"startTime":"0","endTime":"0","summary":"In 2025, the innovative drug sector reached the peak of its bull market. However, Guizhou Bailing Group Pharmaceutical Co., Ltd., which was expected to make breakthroughs in this field and achieve a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0183","BK0146","BK0188","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"1124404737","title":"From Bailout to Legal Battle: Guizhou Bailing and Huachuang Securities' Capital Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=1124404737","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124404737?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:43","pubTimestamp":1765978981,"startTime":"0","endTime":"0","summary":"What began as a financial rescue has devolved into a bitter legal feud between Guizhou Bailing (002424.SZ), known as the \"first Miao medicine stock,\" and Huachuang Securities, the sole securities...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0239","BK0028","BK0077","BK0188","161027","BK0183","BK0146"],"gpt_icon":0},{"id":"1120067919","title":"Guizhou Bailing in Crisis: Controlling Shareholder Under Investigation, 1.7 Billion Relief Funds Turn into Legal Disputes, and Major Losses Followed by New Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=1120067919","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120067919?lang=en_us&edition=fundamental","pubTime":"2025-12-10 10:00","pubTimestamp":1765332042,"startTime":"0","endTime":"0","summary":"Guizhou Bailing Group Pharmaceutical Co., Ltd. recently announced that its controlling shareholder, Jiang Wei, has received a formal investigation notice from the China Securities Regulatory...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0183","BK0146","BK0028","BK0077","BK0188","BK0239"],"gpt_icon":0},{"id":"1110514651","title":"Guizhou Bailing Serves as a Wake-Up Call for Jiang Wei","url":"https://stock-news.laohu8.com/highlight/detail?id=1110514651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110514651?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:51","pubTimestamp":1764939077,"startTime":"0","endTime":"0","summary":"The controlling shareholder of Guizhou Bailing Group Pharmaceutical Co., Ltd., Jiang Wei, has received a \"Notice of Case Filing\" from the China Securities Regulatory Commission (CSRC) for suspected...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0188","BK0028","BK0239","BK0146","BK0077","BK0183"],"gpt_icon":0},{"id":"1165090801","title":"Regulatory Probe \"Double Whammy\"! Guizhou Bailing's Controlling Shareholder Faces Insider Trading Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=1165090801","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165090801?lang=en_us&edition=fundamental","pubTime":"2025-12-05 09:30","pubTimestamp":1764898241,"startTime":"0","endTime":"0","summary":"Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424), known as the \"first Miao medicine stock,\" faces renewed turbulence as its chairman and controlling shareholder Jiang Wei becomes the subject...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0077","002424","BK0028","BK0183","BK0146","BK0188"],"gpt_icon":0},{"id":"1198061503","title":"Guizhou Bailing's Controller and Company Under Investigation; Investors Eligible for Compensation Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1198061503","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198061503?lang=en_us&edition=fundamental","pubTime":"2025-12-05 09:30","pubTimestamp":1764898238,"startTime":"0","endTime":"0","summary":"Investors affected by the recent developments involving Guizhou Bailing Group Pharmaceutical Co., Ltd. (hereinafter referred to as \"Guizhou Bailing\" or \"the Company\") may register for compensation...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0188","BK0183","BK0146","BK0028","BK0077","002424"],"gpt_icon":0},{"id":"1179363028","title":"Company Review: How Can Guizhou Bailing Rebuild Trust After Its Controller Faces Insider Trading and Disclosure Violations Probe?","url":"https://stock-news.laohu8.com/highlight/detail?id=1179363028","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179363028?lang=en_us&edition=fundamental","pubTime":"2025-12-04 13:20","pubTimestamp":1764825642,"startTime":"0","endTime":"0","summary":"On the evening of December 3, Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZ002424, previous closing price: ¥5.57, market cap: ¥7.785 billion) announced that its actual controller, Jiang Wei, has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0239","BK0183","BK0077","002424","BK0146","BK0028"],"gpt_icon":0},{"id":"1103171576","title":"From 1.4 Billion Bailout to Court Battle: Why Did Huachuang Securities and Guizhou Bailing Fall Out?","url":"https://stock-news.laohu8.com/highlight/detail?id=1103171576","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103171576?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:22","pubTimestamp":1764768152,"startTime":"0","endTime":"0","summary":"What went wrong?   Guizhou Bailing (002424.SZ), known as Guizhou's \"first listed ethnic medicine company,\" and Huachuang Securities, the province's only securities firm, initially joined forces for a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0028","BK0146","002424","BK0183","161027","BK0077","BK0239"],"gpt_icon":0},{"id":"1165465095","title":"Guizhou Bailing's Actual Controller Jiang Wei Under Investigation by CSRC for Insider Trading and Disclosure Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=1165465095","media":"Deep News","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165465095?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:10","pubTimestamp":1764760234,"startTime":"0","endTime":"0","summary":"Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424) announced on the evening of December 3 that its actual controller Jiang Wei has been formally investigated by the China Securities Regulatory...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0239","BK0188","002424","BK0146","BK0077","BK0183"],"gpt_icon":0},{"id":"2588632014","title":"BRIEF-Guizhou Bailing Group Pharmaceutical's Actual Controller Investigated For Suspected Rule Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2588632014","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588632014?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:27","pubTimestamp":1764754074,"startTime":"0","endTime":"0","summary":"BRIEF-Guizhou Bailing Group Pharmaceutical's Actual Controller Investigated For Suspected Rule ViolationsDec 3  - Guizhou Bailing Group Pharmaceutical Co Ltd 002424.SZ:SAYS ACTUAL CONTROLLER JIANG WEI INVESTIGATED BY CHINESE SECURITIES REGULATOR FOR SUSPECTED RULE VIOLATIONSSource textFurther company coverage: 002424.SZ  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nL4N3X90NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","002424","BK0239","BK0028","BK0146","BK0183","BK0188"],"gpt_icon":0},{"id":"2588014639","title":"Guizhou Bailing Group Pharmaceutical  Says Actual Controller Jiang Wei Investigated by Securities Regulator for Suspected Rule Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588014639?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:27","pubTimestamp":1764754074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nL4N3X90NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","BK0183","BK0188","002424","BK0146","BK0077","BK0028"],"gpt_icon":0},{"id":"1198349326","title":"Guizhou Bailing (002424) Investor Compensation Case Filed Again in Court, Precedents of Successful Claims Exist for Certain Periods","url":"https://stock-news.laohu8.com/highlight/detail?id=1198349326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198349326?lang=en_us&edition=fundamental","pubTime":"2025-11-21 15:30","pubTimestamp":1763710257,"startTime":"0","endTime":"0","summary":"Investors affected by Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424) can register their claims on the Sina Investor Rights Protection Platform. On November 20, 2025, lawyer Xu Feng from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0183","BK0146","BK0028","BK0077","BK0188","BK0239"],"gpt_icon":0},{"id":"1188078711","title":"Guizhou Bailing Group Pharmaceutical Co.,Ltd. Continues to Face Investor Claims, Eligible Investors Can Still Join","url":"https://stock-news.laohu8.com/highlight/detail?id=1188078711","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188078711?lang=en_us&edition=fundamental","pubTime":"2025-11-19 17:10","pubTimestamp":1763543433,"startTime":"0","endTime":"0","summary":"Investors who suffered losses can register their claims on the Sina Investor Rights Protection Platform. 1. Initial Court Rulings in Favor of Investors   Attorney Liu Peng from Shanghai Huzi Law Firm...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0028","BK0077","BK0183","BK0188","BK0146","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","perCapita":"14973股","boardName":"医药制造业","registeredCapital":"139759万元","compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":0.0215},{"period":"3month","weight":0.025},{"period":"6month","weight":0.1335},{"period":"1year","weight":0.1631},{"period":"ytd","weight":0.1687}],"survey":"　　贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是中成药、中药材、西药、医疗服务。公司已获得国家认定企业技术中心、全国创新型企业、国家火炬计划重点高新技术企业、国家级技术创新示范企业、国家知识产权示范企业、贵州省创新型领军示范企业、贵州省知识产权优势企业等荣誉。","serverTime":1766502747652,"listedPrice":40,"stockholders":"81022人(较上一季度减少2.26%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.,002424,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票老虎,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票老虎国际,Guizhou Bailing Group Pharmaceutical Co.,Ltd.行情,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票行情,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股价,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股市,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票价格,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票交易,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票购买,Guizhou Bailing Group Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guizhou Bailing Group Pharmaceutical Co.,Ltd.(002424) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction